Clinical trial
Platelet Inhibition to Target Reperfusion Injury: The PITRI Trial
NCT03102723 is registered in ClinicalTrials.gov with National Heart Centre Singapore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Platelet Inhibition to Target Reperfusion Injury: The PITRI Trial
- Lead sponsor
- National Heart Centre Singapore
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- October 1, 2017
- Completion date
- December 31, 2022
- Enrollment
- 228 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
stemi